Elevated HIF-1α expression preradiotherapy has been proposed as being a predictive biomarker for suboptimal response to preoperative radiotherapy in patients with laryngeal, oropharyngeal, laryngeal, esophageal, and cervical cancer. This evidence concerns the gene HIF1A and cervical carcinoma.